A Turkish Covid-19 vaccine has shown 100% efficacy against the alpha variant and is currently being tested against the delta variant, the manufacturers said.
Turkovac vaccine expected to be rolled out later this year [Getty/Archive]
A coronavirus vaccine produced in Turkey has shown 100% efficacy against the alpha variant first identified in the UK, the lead scientist behind the vaccine said on Monday.
The Turkovac vaccine, developed at Erciyes University in Turkey’s central province on Kayseri, is currently in its third and final phase of testing.
Principal investigator Professor Aykut Özdarendeli was cited by the Daily sabah saying the vaccine had shown 100 percent efficacy against the alpha variant in tests using transgenic mice. Özdarendeli added that tests on its effectiveness against the delta variant are underway.
The Turkovac vaccine has shown no serious side effects and is expected to be made available to the public later this year, zdarendeli said.
“So far all vaccines have partial side effects and have all been shown to be effective against the coronavirus,” he said.
The new vaccine is expected to bolster Turkey’s vaccination program, which began in January and currently offers the Pfizer-BioNTech vaccine and the Sinovac vaccine developed in China.
Turkish officials say about 40 percent of the country’s population have received two doses as part of their immunization program, according to data from the World Health Organization.
This week Turkey has seen an increase in coronavirus cases, registering more than 20,000.